Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis
Clinical trial NCT02918123 · UNKNOWN
Trial details
- NCT number
- NCT02918123
- Sponsor
- Kang Stem Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-17
- Primary completion
- 2021-12-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.